Regulon

Regulon: R-37

Regulons are regulatory units consisting of a coherently expressed set of genes and the associated regulator(s) whose binding site(s) they share.

Regulon Summary

Regulon summary table displays all associated information related to the specific regulon including the number of genes in the regulon, Hazard ratio, its Regulator, the Transcriptional Program that includes the regulon, Drugs that are associated with members of the regulon, together with mechanism of action and class, and enriched hallmarks of cancer if any.

GenesCox Hazard RatioRegulatorsCausal FlowsTranscriptional ProgramsHallmarks
8-1.2058110Pr-159Self sufficiency in growth signalInsensitivity to antigrowth signalEvading apoptosisSustained angiogenesisTissue invasion and metastasisTumor-promoting inflammationReprogramming energy metabolismEvading immune detectionLimitless replicative potentialGenome instability and mutation

Regulon Genes

List of genes that are included in the regulon. These genes have similar expression profiles in subset of patients and they share common binding motif for the Regulator of the regulon. Clicking on the gene name will take you to the gene specific page with more details. Please wait while information is collated from several resources after you click.

Entrez IDEnsEMBL IDPreferred NameUniprot ID
26277 ENSG00000092330 TINF2 H0YL20
6729 ENSG00000100883 SRP54 P61011
1432 ENSG00000112062 MAPK14 B4E0K5
55795 ENSG00000126226 PCID2 Q5JVF3
54407 ENSG00000134294 SLC38A2 Q96QD8
23589 ENSG00000153048 CARHSP1 Q9Y2V2
11124 ENSG00000185104 FAF1 Q9UNN5
151011 ENSG00000186522 10-Sep Q9P0V9

Regulon Drugs

NameApproved SymbolTypeAction TypeMechanism of ActionMax Trial PhaseMax GBM Phase
FX-005MAPK14Small moleculeINHIBITORMAP kinase p38 alpha inhibitor20
SEMAPIMODMAPK14Small moleculeINHIBITORMAP kinase p38 alpha inhibitor20
TALMAPIMODMAPK14Small moleculeINHIBITORMAP kinase p38 alpha inhibitor20
DILMAPIMODMAPK14Small moleculeINHIBITORMAP kinase p38 alpha inhibitor20
TAK-715MAPK14Small moleculeINHIBITORMAP kinase p38 alpha inhibitor20
NEFLAMAPIMODMAPK14Small moleculeINHIBITORMAP kinase p38 alpha inhibitor20
ARRY-797MAPK14Small moleculeINHIBITORMAP kinase p38 alpha inhibitor30
VX-702MAPK14Small moleculeINHIBITORMAP kinase p38 alpha inhibitor20
RALIMETINIBMAPK14Small moleculeINHIBITORMAP kinase p38 alpha inhibitor21
BMS-582949MAPK14Small moleculeINHIBITORMAP kinase p38 alpha inhibitor20
ACUMAPIMODMAPK14Small moleculeINHIBITORMAP kinase p38 alpha inhibitor20
PF-03715455MAPK14Small moleculeINHIBITORMAP kinase p38 alpha inhibitor20
AZD-7624MAPK14Small moleculeINHIBITORMAP kinase p38 alpha inhibitor20
GSK-610677MAPK14Small moleculeINHIBITORMAP kinase p38 alpha inhibitor10
PEXMETINIBMAPK14Small moleculeINHIBITORTyrosine-protein kinase TIE-2 inhibitor10
LOSMAPIMODMAPK11Small moleculeINHIBITORMAP kinase p38 alpha inhibitor30
DORAMAPIMODMAPK14Small moleculeINHIBITORMAP kinase p38 alpha inhibitor20
PH-797804MAPK14Small moleculeINHIBITORMAP kinase p38 alpha inhibitor20
KC-706MAPK14Small moleculeINHIBITORMAP kinase p38 alpha inhibitor20
PG-760564MAPK14Small moleculeINHIBITORMAP kinase p38 alpha inhibitor20

Causal Flows

Causal Flows are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow a mutation may causally activates or deactivates a downstream regulator which then might up- or down-regulates a regulon that contains genes with similar expression profiles and binding sites.

Causal Mechanistic Flows for Regulon R-37

IDMutationRoleRegulatorRoleRegulon# downstream regulons# diffexp regulonsDrugs